Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.0840
-0.0040 (-4.55%)
Jul 17, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 79.33 million as of July 17, 2026. Its market cap has increased by 49.27% in one year.
Market Cap
79.33M
Enterprise Value
84.54M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 79.33M, a decrease of -59.67%. That is a compound annual growth rate of -16.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 79.33M | -64.64% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 207.54M |
| EMVision Medical Devices | 157.56M |
| Saluda Medical | 133.57M |
| SomnoMed | 100.78M |
| Epiminder | 76.81M |
| Cleo Diagnostics | 49.95M |
| OncoSil Medical | 45.43M |
| Compumedics | 44.95M |